Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7287)
All Articles published online
|
Publishing Process of This Article
|
Oct 14, 2018 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ferrarese A, Germani G, Gambato M, Russo FP, Senzolo M, Zanetto A, Shalaby S, Cillo U, Zanus G, Angeli P, Burra P. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study. World J Gastroenterol 2018; 24(38): 4403-4411 [PMID: 30344424 DOI: 10.3748/wjg.v24.i38.4403] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i38/4403.htm |
| Number | Citing Articles |
| 1 |
Francesco Negro. Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy. Cold Spring Harbor Perspectives in Medicine 2020; 10(4): a036921 doi: 10.1101/cshperspect.a036921
|
| 2 |
Edna STRAUSS. CHRONIC HEPATITIS C IS STILL A PROBLEM FOR THE PUBLIC HEALTH CARE SYSTEM IN BRAZIL. Arquivos de Gastroenterologia 2018; 55(4): 321 doi: 10.1590/s0004-2803.201800000-90
|
| 3 |
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53051-2
|
| 4 |
Sara Battistella, Marco Grasso, Elisa Catanzaro, Francesca D’Arcangelo, Giorgia Corrà, Giacomo Germani, Marco Senzolo, Alberto Zanetto, Alberto Ferrarese, Martina Gambato, Patrizia Burra, Francesco Paolo Russo. Evolution of Liver Transplantation Indications: Expanding Horizons. Medicina 2024; 60(3): 412 doi: 10.3390/medicina60030412
|
| 5 |
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2020; 31(6): 953 doi: 10.1016/j.jvir.2019.12.809
|
| 6 |
Elena Campello, Claudia M. Radu, Alberto Zanetto, Cristiana Bulato, Sarah Shalaby, Luca Spiezia, Enrica Franceschet, Patrizia Burra, Francesco P. Russo, Paolo Simioni. Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals. Liver International 2020; 40(4): 913 doi: 10.1111/liv.14234
|
| 7 |
Martina Gambato, Alberto Ferrarese. Textbook of Liver Transplantation. 2022; : 19 doi: 10.1007/978-3-030-82930-8_2
|
| 8 |
Giuseppe Losurdo, Andrea Iannone, Antonella Contaldo, Michele Barone, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi. Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C. Diagnostics 2020; 10(12): 1037 doi: 10.3390/diagnostics10121037
|
| 9 |
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China. World Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
|
| 10 |
Giuseppina Brancaccio, Alessandro Vitale, Giuseppe Signoriello, Giovanni B. Gaeta, Umberto Cillo. Changing indications for liver transplant: slow decline of hepatitis viruses in Italy. Infectious Diseases 2020; 52(8): 557 doi: 10.1080/23744235.2020.1763453
|
| 11 |
Damiano Patrono, Nicola De Stefano, Renato Romagnoli. Liver transplantation for tumor entities. Current Opinion in Organ Transplantation 2024; 29(4): 255 doi: 10.1097/MOT.0000000000001149
|
| 12 |
Audrey Coilly, Carine Jasseron, Camille Legeai, Filomena Conti, Christophe Duvoux, Nassim Kamar, Sébastien Dharancy, Corinne Antoine. Impact of direct antiviral agents for hepatitis C virus -induced liver diseases on registration, waiting list and liver transplant activity in France. Clinics and Research in Hepatology and Gastroenterology 2023; 47(8): 102168 doi: 10.1016/j.clinre.2023.102168
|
| 13 |
Stella Compagnoni, Erica Maria Bruno, Giorgio Madonia, Marco Cannizzaro, Salvatore Madonia. Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatched. World Journal of Gastroenterology 2021; 27(21): 2771-2783 doi: 10.3748/wjg.v27.i21.2771
|
| 14 |
Yuki Mori, Shuya Matsuda, Mitsuaki Sato, Masaru Muraoka, Yuichiro Suzuki, Akihisa Tatsumi, Yasuhiro Nakayama, Taisuke Inoue, Shinya Maekawa, Nobuyuki Enomoto. The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment. Internal Medicine 2022; 61(18): 2721 doi: 10.2169/internalmedicine.8456-21
|
| 15 |
Egle Ciupkeviciene, Janina Petkeviciene, Jolanta Sumskiene, Gediminas Dragunas, Saulius Dabravalskis, Edita Kreivenaite, Tadas Telksnys, Gediminas Urbonas, Limas Kupcinskas. Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme. Viruses 2022; 14(6): 1192 doi: 10.3390/v14061192
|
| 16 |
G Ireland, R Simmons, M Hickman, M Ramsay, C Sabin, S Mandal. Monitoring liver transplant rates in persons diagnosed with hepatitis C: a data linkage study, England 2008 to 2017.
Eurosurveillance 2019; 24(41) doi: 10.2807/1560-7917.ES.2019.24.41.1900176
|
| 17 |
Wei-Chen Lin, Yang-Sheng Lin, Chen-Wang Chang, Ching-Wei Chang, Tsang-En Wang, Horng-Yuan Wang, Ming-Jen Chen, Chen-Hua Liu. Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma. PLOS ONE 2020; 15(5): e0233212 doi: 10.1371/journal.pone.0233212
|
| 18 |
Patrizia Burra, Debora Bizzaro, Anna Gonta, Sarah Shalaby, Martina Gambato, Maria Cristina Morelli, Silvia Trapani, Annarosa Floreani, Fabio Marra, Maurizia Rossana Brunetto, Gloria Taliani, Erica Villa. Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH). Liver International 2021; 41(8): 1713 doi: 10.1111/liv.14943
|
| 19 |
Renata Senkerikova, Sona Frankova, Milan Jirsa, Miluse Kreidlova, Dusan Merta, Magdalena Neroldova, Klara Chmelova, Julius Spicak, Jan Sperl, Pavel Strnad. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age. PLOS ONE 2019; 14(9): e0222609 doi: 10.1371/journal.pone.0222609
|
| 20 |
Alberto Ferrarese, Sara Battistella, Giacomo Germani, Francesco Paolo Russo, Marco Senzolo, Martina Gambato, Alessandro Vitale, Umberto Cillo, Patrizia Burra. Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy. Medicina 2022; 58(2): 290 doi: 10.3390/medicina58020290
|
| 21 |
Jonathan Li, Vivian Wu, Calvin Q. Pan. Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic review. Hepatology International 2022; 16(5): 1020 doi: 10.1007/s12072-022-10380-1
|
| 22 |
Maheeba Abdulla, Aysha Mohamed Al Ghareeb, Hamed Ali Hasan Yusuf Husain, Nafeesa Mohammed, Jehad Al Qamish. Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C. World Journal of Clinical Cases 2022; 10(34): 12566-12577 doi: 10.12998/wjcc.v10.i34.12566
|
| 23 |
Vijay Gayam, Arshpal Gill, Pavani Garlapati, Smruti Mohanty. Hepatitis B and C. 2020; doi: 10.5772/intechopen.83609
|
| 24 |
Pierluigi Toniutto, Sarah Shalaby, Laura Mameli, Filomena Morisco, Martina Gambato, Valentina Cossiga, Maria Guarino, Fabio Marra, Maurizia R. Brunetto, Patrizia Burra, Erica Villa. Role of sex in liver tumor occurrence and clinical outcomes: A comprehensive review. Hepatology 2024; 79(5): 1141 doi: 10.1097/HEP.0000000000000277
|
| 25 |
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, Sara Battistella, Barbara Penzo, Patrizia Burra, Fabio Farinati. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?. International Journal of Molecular Sciences 2022; 23(1): 500 doi: 10.3390/ijms23010500
|
| 26 |
Hugo Perazzo, Rodolfo Castro, Paula M Luz, Mariana Banholi, Rafaela V Goldenzon, Sandra W Cardoso, Beatriz Grinsztejn, Valdilea G Veloso. Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis. Bulletin of the World Health Organization 2020; 98(3): 188 doi: 10.2471/BLT.19.231522
|
| 27 |
Giacomo Germani, Alberto Ferrarese, Francesca D’Arcangelo, Francesco Paolo Russo, Marco Senzolo, Martina Gambato, Alberto Zanetto, Umberto Cillo, Paolo Feltracco, Paolo Persona, Eugenio Serra, Giuseppe Feltrin, Giovanni Carretta, Alfio Capizzi, Daniele Donato, Michele Tessarin, Patrizia Burra. The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers. United European Gastroenterology Journal 2024; 12(1): 76 doi: 10.1002/ueg2.12475
|
| 28 |
Elio C. Castro Filho, Juliana Piedade, Rodolfo Castro, Paula M. Luz, Flavia Fernandes, Beatriz Grinsztejn, Valdilea G. Veloso, Gustavo Henrique Pereira, Hugo Perazzo. Effectiveness of direct‐acting agents for chronic hepatitis C treatment in South America: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2020; 27(12): 1396 doi: 10.1111/jvh.13364
|
| 29 |
Sanket Mukherjee, Akhil Kumar, Jasmine Samal, Ekta Gupta, Perumal Vivekanandan, Manoj B. Menon. Selective Depletion of ZAP-Binding CpG Motifs in HCV Evolution. Pathogens 2022; 12(1): 43 doi: 10.3390/pathogens12010043
|